Pulmonx Corp Long Term Debt Over Time
| LUNG Stock | USD 7.77 0.07 0.91% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Pulmonx Corp Performance and Pulmonx Corp Correlation. Pulmonx |
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pulmonx Corp. If investors know Pulmonx will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pulmonx Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.44) | Revenue Per Share | Quarterly Revenue Growth 0.233 | Return On Assets | Return On Equity |
The market value of Pulmonx Corp is measured differently than its book value, which is the value of Pulmonx that is recorded on the company's balance sheet. Investors also form their own opinion of Pulmonx Corp's value that differs from its market value or its book value, called intrinsic value, which is Pulmonx Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pulmonx Corp's market value can be influenced by many factors that don't directly affect Pulmonx Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pulmonx Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Pulmonx Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pulmonx Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Long Term Debt Analysis
Compare Pulmonx Corp and related stocks such as Iradimed, Orthofix Medical, and Neuropace Long Term Debt Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| IRMD | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| OFIX | 854 K | 191.2 M | 20 M | 20 M | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 93.1 M | 93.1 M | 93.1 M | 93.1 M | 93.1 M | 157 M | 164.9 M |
| NPCE | 50.8 M | 50.8 M | 50.8 M | 50.8 M | 50.8 M | 50.8 M | 50.8 M | 50.8 M | 50.8 M | 50.8 M | 50.8 M | 49.8 M | 52.9 M | 57 M | 59.5 M | 59.4 M |
| ITGR | 31 M | 235.9 M | 225.4 M | 197.5 M | 176.2 M | 1.7 B | 1.7 B | 1.6 B | 888 M | 777.3 M | 693.8 M | 812.9 M | 907.1 M | 959.9 M | 980.2 M | 604.6 M |
| CNMD | 342.7 M | 89 M | 160.8 M | 214.4 M | 240.2 M | 269.5 M | 488.3 M | 471.7 M | 438.6 M | 755.2 M | 734.8 M | 672.4 M | 985.1 M | 973.1 M | 905.1 M | 950.3 M |
| KIDS | 13.1 M | 13.1 M | 13.1 M | 13.1 M | 13.1 M | 13 M | 17.4 M | 25.3 M | 21.2 M | 26.1 M | 1 M | 907 K | 763 K | 9.9 M | 73 M | 76.6 M |
| SIBN | 15.2 M | 15.2 M | 15.2 M | 15.2 M | 15.2 M | 26 M | 21.1 M | 38.7 M | 39 M | 34.9 M | 39.5 M | 35 M | 35.2 M | 36.1 M | 35.5 M | 35.6 M |
| RXST | 24.4 M | 24.4 M | 24.4 M | 24.4 M | 24.4 M | 24.4 M | 24.4 M | 24.4 M | 24.4 M | 24.4 M | 24.4 M | 43.4 M | 40.2 M | 40.2 M | 46.2 M | 39.6 M |
| AXGN | 4.4 M | 4.4 M | 43.2 M | 25.4 M | 25.1 M | 25.5 M | 20.3 M | 19.9 M | 35 K | 1.6 M | 52.9 M | 65.6 M | 66.1 M | 46.6 M | 47.5 M | 34.9 M |
| TMCI | 19.2 M | 19.2 M | 19.2 M | 19.2 M | 19.2 M | 19.2 M | 19.2 M | 19.2 M | 19.2 M | 19.2 M | 29.2 M | 29.4 M | 52.7 M | 53 M | 53.3 M | 43.4 M |
| LIVN | 397 K | 94 M | 94 M | 94 M | 94 M | 91.8 M | 75.2 M | 62 M | 139.5 M | 260.3 M | 642.3 M | 9.8 M | 518.1 M | 568.5 M | 549.6 M | 577.1 M |
| ELMD | 2.7 M | 1.4 M | 1.3 M | 1.3 M | 1.2 M | 1.2 M | 1.1 M | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| SRDX | 252 K | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 29.4 M | 29.4 M | 29.4 M | 29.4 M | 29.4 M | 29.6 M | 34 M | 35.7 M |
| INGN | 5.1 M | 5.1 M | 5.1 M | 5.4 M | 315 K | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| APYX | 412 K | 3.5 M | 3.4 M | 8.9 M | 15.8 M | 3.3 M | 2.8 M | 2.6 M | 140 K | 33.2 M | 33.2 M | 33.2 M | 33.2 M | 33.2 M | 33.9 M | 35.6 M |
Pulmonx Corp and related stocks such as Iradimed, Orthofix Medical, and Neuropace Long Term Debt description
Long-term debt is a debt that Pulmonx Corp has held for over one year. Long-term debt appears on Pulmonx Corp balance sheet and also includes long-term leases. The most common forms of long term debt are bonds payable, long-term notes payable, mortgage payable, pension liabilities, and lease liabilities. In the corporate world, long-term debt is generally used to fund big-ticket items, such as machinery, buildings, and land. The total of long-term debt reported on Pulmonx Corp balance sheet is the sum of the balances of all categories of long-term debt. Debt that is not due within the current year and is often considered to be financing activities that are to be repaid over several years.My Equities
My Current Equities and Potential Positions
| Pulmonx Corp | LUNG |
Specialization | Health Care, Health Care Equipment & Services |
| Location | California; U.S.A |
| Exchange | NASDAQ Exchange |
USD 7.77
Check out Pulmonx Corp Performance and Pulmonx Corp Correlation. For more detail on how to invest in Pulmonx Stock please use our How to Invest in Pulmonx Corp guide.You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Pulmonx Corp technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.